Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Acarbose on Postprandial Lipoprotein Levels in Glucose Intolerant Patients

NCT02355509 is registered in ClinicalTrials.gov with Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran as lead sponsor.

NCT NCT02355509
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02355509 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Acarbose on Postprandial Lipoprotein Levels in Glucose Intolerant Patients
Lead sponsor
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2010
Completion date
July 31, 2014
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular risk factor, glucose intolerance, postprandial hyperglycemia